Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders.

Alzheimer’s disease amyloid-beta biomarkers cerebrospinal fluid clustering analysis dementia machine learning tau

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2021
Historique:
received: 30 12 2020
accepted: 08 03 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 20 4 2021
Statut: epublish

Résumé

Amyloid-beta (Aβ) 42/40 ratio, tau phosphorylated at threonine-181 (p-tau), and total-tau (t-tau) are considered core biomarkers for the diagnosis of Alzheimer's disease (AD). The use of fully automated biomarker assays has been shown to reduce the intra- and inter-laboratory variability, which is a critical factor when defining cut-off values. The calculation of cut-off values is often influenced by the composition of AD and control groups. Indeed, the clinically defined AD group may include patients affected by other forms of dementia, while the control group is often very heterogeneous due to the inclusion of subjects diagnosed with other neurological diseases (OND). In this context, unsupervised machine learning approaches may overcome these issues providing unbiased cut-off values and data-driven patient stratification according to the sole distribution of biomarkers. In this work, we took advantage of the reproducibility of automated determination of the CSF core AD biomarkers to compare two large cohorts of patients diagnosed with different neurological disorders and enrolled in two centers with established expertise in AD biomarkers. We applied an unsupervised Gaussian mixture model clustering algorithm and found that our large series of patients could be classified in six clusters according to their CSF biomarker profile, some presenting a typical AD-like profile and some a non-AD profile. By considering the frequencies of clinically defined OND and AD subjects in clusters, we subsequently computed cluster-based cut-off values for Aβ42/Aβ40, p-tau, and t-tau. This approach promises to be useful for large-scale biomarker studies aimed at providing efficient biochemical phenotyping of neurological diseases.

Identifiants

pubmed: 33867925
doi: 10.3389/fnins.2021.647783
pmc: PMC8044304
doi:

Types de publication

Journal Article

Langues

eng

Pagination

647783

Informations de copyright

Copyright © 2021 Bellomo, Indaco, Chiasserini, Maderna, Paolini Paoletti, Gaetani, Paciotti, Petricciuolo, Tagliavini, Giaccone, Parnetti and Di Fede.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Biomark Med. 2012 Aug;6(4):391-400
pubmed: 22917141
J Alzheimers Dis Parkinsonism. 2018;8(4):
pubmed: 30473927
Nat Rev Neurosci. 2013 Sep;14(9):626-36
pubmed: 23900411
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Alzheimers Res Ther. 2020 Sep 29;12(1):121
pubmed: 32993776
Clin Chim Acta. 2019 Jul;494:74-78
pubmed: 30878539
J Clin Chem Clin Biochem. 1983 Nov;21(11):709-20
pubmed: 6655447
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Neurology. 2014 Oct 21;83(17):1573-5
pubmed: 25332445
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Neurology. 2009 Dec 1;73(22):1914-22
pubmed: 19949037
Brain. 2015 Sep;138(Pt 9):2716-31
pubmed: 26133663
Alzheimers Res Ther. 2019 Nov 23;11(1):91
pubmed: 31759396
Lancet Neurol. 2007 Aug;6(8):734-46
pubmed: 17616482
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Curr Opin Neurobiol. 2020 Apr;61:29-39
pubmed: 31838254
Neurobiol Aging. 2019 Nov;83:42-53
pubmed: 31585366
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Neurosurg Focus. 2015 Nov;39(5):E2
pubmed: 26646926
Alzheimers Dement. 2014 Nov;10(6):808-17
pubmed: 25150736
Alzheimers Res Ther. 2014 Jan 28;6(1):5
pubmed: 24472496
Front Aging Neurosci. 2018 Aug 22;10:253
pubmed: 30186152
Nat Commun. 2020 Dec 7;11(1):6252
pubmed: 33288742
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
Biomark Med. 2012 Aug;6(4):409-17
pubmed: 22917143
Dement Neuropsychol. 2019 Jul-Sep;13(3):356-360
pubmed: 31555411
Brain. 2016 Aug;139(Pt 8):2261-74
pubmed: 27324877
Clin Chem. 2006 Feb;52(2):332-4
pubmed: 16449222
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
J Biomed Inform. 2018 Sep;85:30-39
pubmed: 30016722
Stat Med. 2000 May 15;19(9):1141-64
pubmed: 10797513
Ann Clin Transl Neurol. 2019 Sep;6(9):1815-1824
pubmed: 31464088
Parkinsonism Relat Disord. 2018 Apr;49:9-16
pubmed: 29310988
Curr Atheroscler Rep. 2003 Jul;5(4):260-6
pubmed: 12793966
Diagnostics (Basel). 2020 Nov 26;10(12):
pubmed: 33256252
Trends Pharmacol Sci. 2020 Dec;41(12):1023-1037
pubmed: 33127098
Clin Chim Acta. 2019 Jul;494:71-73
pubmed: 30844364
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Sci Rep. 2018 Feb 19;8(1):3269
pubmed: 29459625
Neurosurgery. 2005 Sep;57(3 Suppl):S4-16; discussion ii-v
pubmed: 16160425
Science. 2006 Nov 3;314(5800):777-81
pubmed: 17082447
Neurology. 1999 Sep 22;53(5):1159
pubmed: 10496296
Alzheimers Res Ther. 2018 Mar 20;10(1):32
pubmed: 29558979
Mov Disord. 2007 Sep 15;22(12):1689-707; quiz 1837
pubmed: 17542011
J Clin Mov Disord. 2017 Mar 2;4:2
pubmed: 28265458
Semin Neurol. 2019 Apr;39(2):213-226
pubmed: 30925614
Arch Neurol. 2000 Aug;57(8):1171-6
pubmed: 10927797
Clin Chem. 2015 May;61(5):734-43
pubmed: 25869575

Auteurs

Giovanni Bellomo (G)

Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Antonio Indaco (A)

Neurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Davide Chiasserini (D)

Section of Biochemistry, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Emanuela Maderna (E)

Neurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Federico Paolini Paoletti (F)

Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Lorenzo Gaetani (L)

Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Silvia Paciotti (S)

Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Maya Petricciuolo (M)

Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Fabrizio Tagliavini (F)

Neurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Giorgio Giaccone (G)

Neurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Lucilla Parnetti (L)

Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Giuseppe Di Fede (G)

Neurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico C. Besta, Milan, Italy.

Classifications MeSH